Showing results (561-570 of 703) with videos related to

Sort By:
Pageof 71
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamideC S Portlock, J Qin, P Schaindlin, et al.
Frontiers in Immunology|January 9, 2023
Heat stress increases immune cell function in HexacoralliaShir Eliachar, Grace Ann Snyder, Shany Klara Barkan, et al.
European Journal of Haematology|June 30, 2018
SMYD1 is the underlying gene for the AnWj-negative blood group phenotypeVered Yahalom, Nir Pillar, Yingying Zhao, et al.
International Journal of Molecular Sciences|July 13, 2024
GBA1-Associated Parkinson's Disease Is a Distinct EntityAliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, et al.
Blood|January 24, 2004
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Stephen D Nimer, et al.
Journal for Immunotherapy of Cancer|June 19, 2022
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockadeMichal Harel, Coren Lahav, Eyal Jacob, et al.
Health Physics|January 1, 2014
Second malignant neoplasms and cardiovascular disease following radiotherapyLois B Travis, Andrea K Ng, James M Allan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 3, 2021
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief ReportJenna M Kahn, Joanna C Yang, Joachim Yahalom, et al.
Journal of the National Cancer Institute|February 8, 2012
Second malignant neoplasms and cardiovascular disease following radiotherapyLois B Travis, Andrea K Ng, James M Allan, et al.
Orphanet Journal of Rare Diseases|August 7, 2021
Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi studyBianca M L Stelten, Maria Teresa Dotti, Aad Verrips, et al.
Pageof 71